According to the research report, the global market for Group A and Group C Meningococcal Polysaccharide Vaccine should grow from US$ 285 million in 2022 to US$ 425.5 million by 2029, with a CAGR of 5.9% for the period of 2023-2029.

Meningococcal disease, caused by Neisseria meningitidis, can cause serious illness and even death. The global burden of meningococcal disease, especially serogroups A and C, drives the need for effective vaccines to prevent these infections.

After vaccination, the body can produce a humoral immune response. It is used to prevent infectious diseases caused by group A and group C meningococci, such as cerebrospinal meningitis and pneumonia.

This report aims to provide a comprehensive study of the global market for Group A and Group C Meningococcal Polysaccharide Vaccine. Report Highlights:

(1) Global Group A and Group C Meningococcal Polysaccharide Vaccine market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Group A and Group C Meningococcal Polysaccharide Vaccine market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(3) China Group A and Group C Meningococcal Polysaccharide Vaccine market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(4) Global Group A and Group C Meningococcal Polysaccharide Vaccine segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Group A and Group C Meningococcal Polysaccharide Vaccine segment by type and by application and regional segment by type and by application.

(6) Global major production regions of Group A and Group C Meningococcal Polysaccharide Vaccine, capacity, production and trends.

(7) Group A and Group C Meningococcal Polysaccharide Vaccine industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Class 1 Vaccine

Class II Vaccine

Market segment by application, can be divided into

Hospital

Clinic

Market segment by players, this report covers

Walvax

Lanzhou Institute of Biological Products

AIM Bio

Sanofi Pasteur

GSK

Hualan Bio

ZFSW

Changsheng

Kanghua Bio

1 Market Overview

1.1 Group A and Group C Meningococcal Polysaccharide Vaccine Definition

1.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Forecast

1.2.1 By Revenue, Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029

1.2.2 By Sales Volume, Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029

1.2.3 Global Group A and Group C Meningococcal Polysaccharide Vaccine Price Trend, 2018-2029

1.3 China Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Forecast

1.3.1 By Revenue, China Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029

1.3.2 By Sales Volume, China Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029

1.3.3 China Group A and Group C Meningococcal Polysaccharide Vaccine Price Trend, 2018-2029

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Group A and Group C Meningococcal Polysaccharide Vaccine Share in Global Market, 2018-2029

1.4.2 By Sales Volume, China Group A and Group C Meningococcal Polysaccharide Vaccine Share in Global Market, 2018-2029

1.4.3 Group A and Group C Meningococcal Polysaccharide Vaccine Market Size: China VS Global, 2018-2029

1.5 Group A and Group C Meningococcal Polysaccharide Vaccine Market Dynamics

1.5.1 Group A and Group C Meningococcal Polysaccharide Vaccine Market Drivers

1.5.2 Group A and Group C Meningococcal Polysaccharide Vaccine Market Restraints

1.5.3 Group A and Group C Meningococcal Polysaccharide Vaccine Industry Trends

1.5.4 Group A and Group C Meningococcal Polysaccharide Vaccine Industry Policy

2 Global Competitive Landscape by Company

2.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue by Company, 2018-2023

2.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume by Company, 2018-2023

2.3 Global Group A and Group C Meningococcal Polysaccharide Vaccine Price by Company, 2018-2023

2.4 Global Group A and Group C Meningococcal Polysaccharide Vaccine Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global Group A and Group C Meningococcal Polysaccharide Vaccine Concentration Ratio

2.6 Global Group A and Group C Meningococcal Polysaccharide Vaccine Mergers & Acquisitions, Expansion Plans

2.7 Global Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China Group A and Group C Meningococcal Polysaccharide Vaccine Revenue by Company, 2018-2023

3.2 China Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume by Company, 2018-2023

3.3 China Group A and Group C Meningococcal Polysaccharide Vaccine Group A and Group C Meningococcal Polysaccharide Vaccine Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China Group A and Group C Meningococcal Polysaccharide Vaccine Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)

3.5 Chinese Local Players, Group A and Group C Meningococcal Polysaccharide Vaccine Domestic VS Export

3.6 China Market, Group A and Group C Meningococcal Polysaccharide Vaccine Import & Export

3.6.1 China Market, Group A and Group C Meningococcal Polysaccharide Vaccine Import & Export, 2018-2029

3.6.2 China Group A and Group C Meningococcal Polysaccharide Vaccine Import & Export Trends

3.6.3 Main Sources of China Group A and Group C Meningococcal Polysaccharide Vaccine Import

3.6.4 Export Destination of China Group A and Group C Meningococcal Polysaccharide Vaccine

4 Group A and Group C Meningococcal Polysaccharide Vaccine Production by Region

4.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Capacity, Production and Capacity Utilization, 2018-2029

4.2 Global Geographic Distribution of Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers

4.3 Global Major Manufacturers, Group A and Group C Meningococcal Polysaccharide Vaccine Capacity Expansion and Future Plans

4.4 Global Group A and Group C Meningococcal Polysaccharide Vaccine Capacity by Region

4.5 Global Group A and Group C Meningococcal Polysaccharide Vaccine Production by Region

4.5.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029

4.5.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Production by Region, 2018-2023

4.5.3 Global Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share & Forecast by Region, 2018-2029

5 Industry Chain Analysis

5.1 Group A and Group C Meningococcal Polysaccharide Vaccine Industry Chain

5.2 Group A and Group C Meningococcal Polysaccharide Vaccine Upstream Analysis

5.2.1 Group A and Group C Meningococcal Polysaccharide Vaccine Core Raw Materials

5.2.2 Main Manufacturers of Group A and Group C Meningococcal Polysaccharide Vaccine Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Group A and Group C Meningococcal Polysaccharide Vaccine Production Mode

5.6 Group A and Group C Meningococcal Polysaccharide Vaccine Procurement Model

5.7 Group A and Group C Meningococcal Polysaccharide Vaccine Industry Sales Model and Sales Channels

5.7.1 Group A and Group C Meningococcal Polysaccharide Vaccine Sales Model

5.7.2 Group A and Group C Meningococcal Polysaccharide Vaccine Typical Distributors

6 Sights by Type

6.1 Group A and Group C Meningococcal Polysaccharide Vaccine Classification

6.1.1 Class 1 Vaccine

6.1.2 Class II Vaccine

6.2 By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue, 2018-2029

6.4 By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029

6.5 By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Price, 2018-2029

7 Sights by Application

7.1 Group A and Group C Meningococcal Polysaccharide Vaccine Segment by Application

7.1.1 Hospital

7.1.2 Clinic

7.2 By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size & CAGR, 2018 VS 2022 VS 2029

7.3 By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue, 2018-2029

7.4 By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029

7.5 By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Price, 2018-2029

8 Sales Sights by Region

8.1 By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018 VS 2022 VS 2029

8.2 By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue, 2018-2029

8.3 By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029

8.4 North America

8.4.1 North America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size & Forecasts, 2018-2029

8.4.2 By Country, North America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Market Share

8.5 Europe

8.5.1 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size & Forecasts, 2018-2029

8.5.2 By Country, Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Market Size & Forecasts, 2018-2029

8.6.2 By Country/Region, Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Market Share

8.7 South America

8.7.1 South America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size & Forecasts, 2018-2029

8.7.2 By Country, South America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size & CAGR，2018 VS 2022 VS 2029

9.2 By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue, 2018-2029

9.3 By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029

9.4 U.S.

9.4.1 U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029

9.4.2 By Company, U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022

9.4.3 By Type, U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029

9.4.4 By Application, U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029

9.5 Europe

9.5.1 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029

9.5.2 By Company, Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022

9.5.3 By Type, Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029

9.5.4 By Application, Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029

9.6 China

9.6.1 China Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029

9.6.2 By Company, China Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022

9.6.3 By Type, China Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029

9.6.4 By Application, China Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029

9.7 Japan

9.7.1 Japan Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029

9.7.2 By Company, Japan Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022

9.7.3 By Type, Japan Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029

9.7.4 By Application, Japan Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029

9.8 South Korea

9.8.1 South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029

9.8.2 By Company, South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022

9.8.3 By Type, South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029

9.8.4 By Application, South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029

9.9 Southeast Asia

9.9.1 Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029

9.9.2 By Company, Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022

9.9.3 By Type, Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029

9.9.4 By Application, Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029

9.10 India

9.10.1 India Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029

9.10.2 By Company, India Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022

9.10.3 By Type, India Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029

9.10.4 By Application, India Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029

9.11 Middle East & Asia

9.11.1 Middle East & Asia Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029

9.11.2 By Company, Middle East & Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022

9.11.3 By Type, Middle East & Asia Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029

9.11.4 By Application, Middle East & Asia Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, Share, 2022 VS 2029

10 Manufacturers Profile

10.1 Walvax

10.1.1 Walvax Company Information, Head Office, Market Area and Industry Position

10.1.2 Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application

10.1.3 Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.1.4 Walvax Company Profile and Main Business

10.1.5 Walvax Recent Developments

10.2 Lanzhou Institute of Biological Products

10.2.1 Lanzhou Institute of Biological Products Company Information, Head Office, Market Area and Industry Position

10.2.2 Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application

10.2.3 Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.2.4 Lanzhou Institute of Biological Products Company Profile and Main Business

10.2.5 Lanzhou Institute of Biological Products Recent Developments

10.3 AIM Bio

10.3.1 AIM Bio Company Information, Head Office, Market Area and Industry Position

10.3.2 AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application

10.3.3 AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.3.4 AIM Bio Company Profile and Main Business

10.3.5 AIM Bio Recent Developments

10.4 Sanofi Pasteur

10.4.1 Sanofi Pasteur Company Information, Head Office, Market Area and Industry Position

10.4.2 Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application

10.4.3 Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.4.4 Sanofi Pasteur Company Profile and Main Business

10.4.5 Sanofi Pasteur Recent Developments

10.5 GSK

10.5.1 GSK Company Information, Head Office, Market Area and Industry Position

10.5.2 GSK Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application

10.5.3 GSK Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.5.4 GSK Company Profile and Main Business

10.5.5 GSK Recent Developments

10.6 Hualan Bio

10.6.1 Hualan Bio Company Information, Head Office, Market Area and Industry Position

10.6.2 Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application

10.6.3 Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.6.4 Hualan Bio Company Profile and Main Business

10.6.5 Hualan Bio Recent Developments

10.7 ZFSW

10.7.1 ZFSW Company Information, Head Office, Market Area and Industry Position

10.7.2 ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application

10.7.3 ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.7.4 ZFSW Company Profile and Main Business

10.7.5 ZFSW Recent Developments

10.8 Changsheng

10.8.1 Changsheng Company Information, Head Office, Market Area and Industry Position

10.8.2 Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application

10.8.3 Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.8.4 Changsheng Company Profile and Main Business

10.8.5 Changsheng Recent Developments

10.9 Kanghua Bio

10.9.1 Kanghua Bio Company Information, Head Office, Market Area and Industry Position

10.9.2 Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application

10.9.3 Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.9.4 Kanghua Bio Company Profile and Main Business

10.9.5 Kanghua Bio Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Group A and Group C Meningococcal Polysaccharide Vaccine Market Size & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Group A and Group C Meningococcal Polysaccharide Vaccine Market Restraints

Table 3. Group A and Group C Meningococcal Polysaccharide Vaccine Market Trends

Table 4. Group A and Group C Meningococcal Polysaccharide Vaccine Industry Policy

Table 5. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue by Company, 2018-2023, US$ million

Table 6. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share by Company, 2018-2023

Table 7. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume by Company, 2018-2023, (K Units)

Table 8. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share by Company, 2018-2023

Table 9. Global Group A and Group C Meningococcal Polysaccharide Vaccine Price by Company, 2018-2023, (US$/Unit)

Table 10. Global Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Group A and Group C Meningococcal Polysaccharide Vaccine Mergers & Acquisitions, Expansion Plans

Table 12. Global Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers Product Type

Table 13. China Group A and Group C Meningococcal Polysaccharide Vaccine Revenue by Company, 2018-2023, US$ million

Table 14. China Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share by Company, 2018-2023

Table 15. China Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume by Company, 2018-2023, (K Units)

Table 16. China Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share by Company, 2018-2023

Table 17. China Market, Group A and Group C Meningococcal Polysaccharide Vaccine Production, Sales, Import and Export, 2018-2029, (K Units)

Table 18. China Group A and Group C Meningococcal Polysaccharide Vaccine Import & Export Trends

Table 19. Main Sources of China Group A and Group C Meningococcal Polysaccharide Vaccine Import

Table 20. Export Destination of China Group A and Group C Meningococcal Polysaccharide Vaccine

Table 21. Global Headquarters and Manufacturing Base of Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers

Table 22. Global Major Manufacturers, Group A and Group C Meningococcal Polysaccharide Vaccine Capacity Expansion and Future Plans

Table 23. Global Group A and Group C Meningococcal Polysaccharide Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 24. Global Group A and Group C Meningococcal Polysaccharide Vaccine Production by Region, 2018-2023, (K Units)

Table 25. Global Group A and Group C Meningococcal Polysaccharide Vaccine Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of Group A and Group C Meningococcal Polysaccharide Vaccine Upstream (Raw Materials)

Table 27. Global Group A and Group C Meningococcal Polysaccharide Vaccine Typical Customers

Table 28. Group A and Group C Meningococcal Polysaccharide Vaccine Typical Distributors

Table 29. By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 31. By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 32. By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue, 2018-2029, US$ Million

Table 33. By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029, (K Units)

Table 34. By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 35. By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue, 2018-2029, US$ Million

Table 36. By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029

Table 37. By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029, (K Units)

Table 38. By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2018-2029

Table 39. Walvax Company Information, Head Office, Market Area and Industry Position

Table 40. Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application

Table 41. Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Walvax Company Profile and Main Business

Table 43. Walvax Recent Developments

Table 44. Lanzhou Institute of Biological Products Company Information, Head Office, Market Area and Industry Position

Table 45. Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application

Table 46. Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. Lanzhou Institute of Biological Products Company Profile and Main Business

Table 48. Lanzhou Institute of Biological Products Recent Developments

Table 49. AIM Bio Company Information, Head Office, Market Area and Industry Position

Table 50. AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application

Table 51. AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. AIM Bio Company Profile and Main Business

Table 53. AIM Bio Recent Developments

Table 54. Sanofi Pasteur Company Information, Head Office, Market Area and Industry Position

Table 55. Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application

Table 56. Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Sanofi Pasteur Company Profile and Main Business

Table 58. Sanofi Pasteur Recent Developments

Table 59. GSK Company Information, Head Office, Market Area and Industry Position

Table 60. GSK Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application

Table 61. GSK Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. GSK Company Profile and Main Business

Table 63. GSK Recent Developments

Table 64. Hualan Bio Company Information, Head Office, Market Area and Industry Position

Table 65. Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application

Table 66. Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. Hualan Bio Company Profile and Main Business

Table 68. Hualan Bio Recent Developments

Table 69. ZFSW Company Information, Head Office, Market Area and Industry Position

Table 70. ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application

Table 71. ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. ZFSW Company Profile and Main Business

Table 73. ZFSW Recent Developments

Table 74. Changsheng Company Information, Head Office, Market Area and Industry Position

Table 75. Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application

Table 76. Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. Changsheng Company Profile and Main Business

Table 78. Changsheng Recent Developments

Table 79. Kanghua Bio Company Information, Head Office, Market Area and Industry Position

Table 80. Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications and Application

Table 81. Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 82. Kanghua Bio Company Profile and Main Business

Table 83. Kanghua Bio Recent Developments

List of Figure

Figure 1. Group A and Group C Meningococcal Polysaccharide Vaccine Picture

Figure 2. By Revenue, Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Forecast, 2018-2029, US$ Million

Figure 3. By Sales Volume, Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Forecast, 2018-2029, (K Units)

Figure 4. Global Group A and Group C Meningococcal Polysaccharide Vaccine Price Trend, 2018-2029, (US$/Unit)

Figure 5. By Revenue, China Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Forecast, 2018-2029, US$ million

Figure 6. By Sales Volume, China Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Forecast, 2018-2029, (K Units)

Figure 7. China Group A and Group C Meningococcal Polysaccharide Vaccine Price Trend, 2018-2029 (US$/Unit)

Figure 8. By Revenue, China Group A and Group C Meningococcal Polysaccharide Vaccine Share of Global Market, 2018-2029

Figure 9. By Sales Volume, China Group A and Group C Meningococcal Polysaccharide Vaccine Share of Global Market, 2018-2029

Figure 10. Global Group A and Group C Meningococcal Polysaccharide Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Group A and Group C Meningococcal Polysaccharide Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Group A and Group C Meningococcal Polysaccharide Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Group A and Group C Meningococcal Polysaccharide Vaccine Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 15. Chinese Local Players, Proportion of Group A and Group C Meningococcal Polysaccharide Vaccine Domestic VS Export, 2022

Figure 16. Global Group A and Group C Meningococcal Polysaccharide Vaccine Capacity, Production and Capacity Utilization, 2018-2029

Figure 17. Global Group A and Group C Meningococcal Polysaccharide Vaccine Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share & Forecast by Region, 2018-2029

Figure 19. Group A and Group C Meningococcal Polysaccharide Vaccine Industry Chain

Figure 20. Group A and Group C Meningococcal Polysaccharide Vaccine Procurement Model

Figure 21. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Model

Figure 22. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Channels, Direct Sales and Distribution

Figure 23. Class 1 Vaccine

Figure 24. Class II Vaccine

Figure 25. By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue, 2018-2029, US$ Million

Figure 26. By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029

Figure 27. By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029, (K Units)

Figure 28. By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2018-2029

Figure 29. By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Price, 2018-2029, (US$/Unit)

Figure 30. Hospital

Figure 31. Clinic

Figure 32. By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue, 2018-2029, US$ Million

Figure 33. By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029

Figure 34. By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029, (K Units)

Figure 35. By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2018-2029

Figure 36. By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Price, 2018-2029, (US$/Unit)

Figure 37. By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029

Figure 38. By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2018-2029

Figure 39. North America Group A and Group C Meningococcal Polysaccharide Vaccine Revenue & Forecasts, 2018-2029, US$ Million

Figure 40. By Country, North America Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share, 2022

Figure 41. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Revenue & Forecasts, 2018-2029, US$ Million

Figure 42. By Country, Europe Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share, 2022

Figure 43. Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Revenue & Forecasts, 2018-2029, US$ Million

Figure 44. By Country/Region, Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share, 2022

Figure 45. South America Group A and Group C Meningococcal Polysaccharide Vaccine Revenue & Forecasts, 2018-2029, US$ Million

Figure 46. By Country, South America Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Market Share, 2022

Figure 47. Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Revenue & Forecasts, 2018-2029, US$ Million

Figure 48. U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029, (K Units)

Figure 49. By Company, U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Market Share, 2022

Figure 50. By Type, U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 51. By Application, U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 52. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029, (K Units)

Figure 53. By Company, Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Share, 2022

Figure 54. By Type, Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 55. By Application, Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 56. China Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029, (K Units)

Figure 57. By Company, China Group A and Group C Meningococcal Polysaccharide Vaccine Market Share, 2022

Figure 58. By Type, China Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 59. By Application, China Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 60. Japan Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029, (K Units)

Figure 61. By Company, Japan Group A and Group C Meningococcal Polysaccharide Vaccine Market Share, 2022

Figure 62. By Type, Japan Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 63. By Application, Japan Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 64. South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029, (K Units)

Figure 65. By Company, South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Market Share, 2022

Figure 66. By Type, South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 67. By Application, South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 68. Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029, (K Units)

Figure 69. By Company, Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Market Share, 2022

Figure 70. By Type, Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 71. By Application, Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 72. India Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029, (K Units)

Figure 73. By Company, India Group A and Group C Meningococcal Polysaccharide Vaccine Market Share, 2022

Figure 74. By Type, India Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 75. By Application, India Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 76. Middle East & Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume, 2018-2029, (K Units)

Figure 77. By Company, Middle East & Asia Group A and Group C Meningococcal Polysaccharide Vaccine Market Share, 2022

Figure 78. By Type, Middle East & Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 79. By Application, Middle East & Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 80. Research Methodology

Figure 81. Breakdown of Primary Interviews

Figure 82. Bottom-up Approaches

Figure 83. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)